Progyny, Inc.·4

Apr 3, 5:23 PM ET

Sturmer Michael E 4

4 · Progyny, Inc. · Filed Apr 3, 2024

Insider Transaction Report

Form 4
Period: 2024-03-04
Transactions
  • Sale

    Common Stock

    2024-04-01$37.60/sh4,515$169,764386,433 total
  • Award

    Stock Option (Right to Buy)

    2024-03-04+600,000600,000 total
    Exercise: $35.48Exp: 2034-03-03Common Stock (600,000 underlying)
  • Award

    Common Stock

    2024-03-04+250,000390,948 total
  • Sale

    Common Stock

    2024-04-01$37.60/sh1,880$70,688384,553 total
Footnotes (3)
  • [F1]Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the RSUs will vest on March 4, 2025 with the remaining RSUs vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 31, 2023.
  • [F3]Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 25% of the shares subject to the option will vest on March 4, 2025 with the remaining shares subject to the option vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.

Documents

1 file
  • 4
    wk-form4_1712179367.xmlPrimary

    FORM 4